XML 34 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
7. Stockholders equity (Tables)
3 Months Ended
Dec. 31, 2012
Equity [Abstract]  
Warrrants outstanding

The number of shares of common stock subject to exercise and the exercise price of all options and warrants outstanding at December 31, 2012 is as follows:

 

Shares Outstanding     Weighted Average Exercise Price     Shares Vested   Expiration Fiscal Period
                       
  2,805,600     $ 1.45       2,805,600   4th Qtr, 2013
  40,000       0.01       40,000   3rd Qtr, 2014
  200,000       1.25       200,000   4th Qtr, 2014
  108,500       0.40       108,500   1st Qtr, 2015
  104,000       0.19       104,000   2nd Qtr. 2015
  30,000       0.53       30,000   4th Qtr, 2016
  50,000       0.50       50,000   1st Qtr, 2017
  50,000       0.50       50,000   2nd Qtr. 2017
  1,079,000       0.55       740,452   4th Qtr, 2021
  125,000       0.53       41,665   1st Qtr, 2022
  35,000       0.53       10,208   2nd Qtr, 2022
  1,462       3.25       1,462   3rd Qtr, 2022
  52,000       0.75       -   1st Qtr, 2023
  4,680,562               4,181,887    
Weighted average assumptions for Black-Scholes-Merton option pricing formula

The following weighted average assumptions were used for the calculations during the three months ended December 31, 2012:

 

Expected life (in years)   3.74 years  
Weighted average volatility     135.89 %
Forfeiture rate     20.00 %
Risk-free interest rate     1.06 %
Expected dividend rate     - %
Exercise prices for options and warrants granted and outstanding which resulted in stock based compensation charges

The exercise prices for options and warrants granted and outstanding which resulted in stock based compensation charges was as follows at December 31, 2012:

 

Exercise Price Range   Number of options or warrants
  $ 0.25 - 0.50   100,000
  $ 0.51 – 0.75   1,297,000
  $ 0.76 - 1.00   -
  $ 1.01 - 1.25   624,000
  $ 1.26 - 2.00   32,500
  $ 2.01 - 3.00   -
  $ 3.01 - 4.00   1,462
        2,054,962

 

Summary of non-vested options and warrants

A summary of the status of our non-vested options and warrants as of December 31, 2012 and changes during the three months then ended is as follows:

 

    Shares  
Non-vested outstanding, October 1, 2012     613,360  
Granted     152,000  
Vested     (266,685 )
Cancelled     -  
Non-vested outstanding, December 31, 2012     498,675  

 

Shares of common stock reserved for future issuance

The following table summarizes shares of our common stock reserved for future issuance at December 31, 2012:

 

Stock options outstanding     1,133,462  
Stock options available for future grant under the 2011 Plan     366,538  
Warrants     3,547,100  
Total common shares reserved for future issuance     5,047,100